Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of linaclotide in children and adolescents with functional constipation
MOH_2020-09-08_009299Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional constipation (FC) comparing Linaclotide 72 mcg daily with Placebo (2 arms). Started Sep 2020; status: completed.
02
Drugs
linaclotide
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on MOH_2020-09-08_009299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-09-08_009299.